Prova en annan sökning
Fonden investerar främst i aktier i bioteknik- och forskningsföretag (inklusive små och medelstora företag) belägna i USA och i andra länder. Bioteknikverksamhet är forskning, utveckling, tillverkning och distribution av olika bioteknikrelaterade eller biomedicinska produkter, tjänster och metoder. Detta kan omfatta företag som ägnar sig åt genomik, genetisk genteknik och genterapi. Det omfattar även företag som ägnar sig åt tillämpning och utveckling av bioteknik inom områden som hälsovård, läkemedel och jordbruk. Fondens analys- och förvaltningsteam är baserade i Silicon Valley i USA.
Namn | Titel | Sedan | Till |
---|---|---|---|
Akiva Felt | - | 2020 | Nu |
Biografi | Mr. Felt has been a portfolio manager, providing research and advice on the purchases and sales of individual securities and portfolio risk assessment. He joined Franklin Templeton in 2018. Prior to joining Franklin Templeton, Mr. Felt was a Senior Research Analyst with Asymmetry Capital, a healthcare focused hedge fund. He has covered the biotechnology sector since 2007 in increasing capacities on the sell-side, most recently as Managing Director for Oppenheimer & Co. | ||
Wendy Lam | Portfolio Manager | 2018 | Nu |
Biografi | Ms. Lam has joined Franklin Templeton Investments in 2016. Prior to joining Franklin Templeton, Ms. Lam was an Executive Director and Senior Analyst covering large-cap biotechnology for Oppenheimer & Co and had been an Equity Research Associate at Bank of America Merrill Lynch, Morgan Stanley and Oppenheimer & Co. Ms. Lam has a Ph.D degree. | ||
Evan S. McCulloch | Vice President | 2000 | Nu |
Biografi | Mr. McCulloch, CFA, joined Franklin Templeton Investments in 1992. | ||
Steven Kornfeld | Portfolio Manager | 2015 | 2020 |
Biografi | Steven Kornfeld is VP, Research Analyst and Portfolio Manager with Franklin Equity Group. He specializes in research analysis of the pharmaceutical industry and is a member of the Franklin Core/Hybrid team. Prior to joining Franklin Templeton Investments in January 2001, Mr. Kornfeld most recently worked in private equity and previously as a sell-side research analyst where he specialized in covering emerging growth companies. He holds an MBA from Northwestern University and a bachelor’s degree from the Wharton School of Business at the University of Pennsylvania. He is a CFA®* Charterholder. | ||
Jerel A. Banks | senior equity research analyst | 2012 | 2015 |
Biografi | JEREL A. Banks has been a portfolio manager of the Fund since September 2012, providing research and advice on the purchases and sales of individual securities and portfolio risk assessment. He joined Franklin Templeton Investments in 2012. Prior to joining Franklin Templeton Investments, he was a senior equity research analyst at Sectoral Asset Management and Apothecary Capital and an equity research associate at Capital Research and Management. | ||
Vincent Xiang | Manager | 2004 | 2011 |
Biografi | Xiang is a manager of the fund providing research and advice on the purchases and sales of individual securities and portfolio risk assessment. He joined Franklin Templeton Investments in 2004. Previously, Xiang was a vice president of business development at Genyous Life Sciences, Inc. He also worked on deal sourcing, due diligence and strategic planning at BioAdvance and as a senior analyst for Acacia Research Corporation. | ||
Kurt von Emster | Portfolio Manager | 2000 | 2000 |
Biografi | Von Emster is currently a portfolio manager with Franklin Advisers. He joined the firm in 1989 as a management trainee and securities analyst. Previously, he was a purchasing agent for the University of California at Santa Barbara's Marine Science Institute. Von Emster is a Chartered Financial Analyst and a member of the Security Analysts of San Francisco. |
Är du säker på att du vill blockera %USER_NAME%?
Genom att blockera kan du och %USER_NAME% inte se varandras inlägg på Investing.com.
%USER_NAME% lyckades läggas till i din Blockeringslista
Eftersom du precis avblockerat denna person måste du vänta 48 timmar för att kunna förnya blockeringen.
Jag anser att denna kommentar är:
Tack!
Rapporten har skickats till våra moderatorer för granskning